Skip to Main Content

Paper Details

Tumor lenvatinib addiction and withdrawal rebound response in patients with advanced endometrial cancer.
Gynecol Oncol Rep
0
2023
Author NameAffiliation
Britta WeigeltMemorial Sloan Kettering Cancer Center
  • 1 - 1

Datasets

Release 1.2